Hemp & GLA: Good Fat Burns Bad Fat                   (article – undated)  http://manitobaharvest.com/articles_studies/3813/Hemp-%26amp%3B-GLA%3A-Good-Fat-Burns-Bad-  Fat-.html


Effects of smoked marijuana on food intake and body weight of humans living in a residential laboratory.                                                         (abst – 1988)



Low dose anandamide affects food intake, cognitive function, neurotransmitter and corticosterone levels in diet-restricted mice.                                                                   (abst – 2000)  http://www.ncbi.nlm.nih.gov/pubmed/10762668


Dietary intake and nutritional status of US adult marijuana users: results from the Third National Health and Nutrition Examination Survey.                                                       (full – 2001)  http://journals.cambridge.org/action/displayFulltext?type=6&fid=626876&jid=PHN&volumeId=4&issueId

=03&aid=562676&bodyId=&membershipNumber=&societyETOCSession=&fulltextType=RA&fileId=S1  368980001000738


Marijuana “Munchies” May Hold a Key to Obesity                      (news – 2001)



The endogenous cannabinoid system affects energy balance via central orexigenic drive and peripheral lipogenesis                                                                (full – 2003)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC166293/


Endocannabinoids and the regulation of body fat: the smoke is clearing                    (full – 2003)



Short-term fasting and prolonged semistarvation have opposite effects on 2-AG levels in mouse brain.    (abst – 2003)                                 http://www.ncbi.nlm.nih.gov/pubmed/12914975


CB1 cannabinoid receptor knockout in mice leads to leanness, resistance to diet-induced obesity and enhanced leptin sensitivity                                                        (full – 2004)  http://www.nature.com/ijo/journal/v28/n4/full/0802583a.html


Activation of the Peripheral Endocannabinoid System in Human Obesity                   (full – 2005)



Endocannabinoid activation at hepatic CB1 receptors stimulates fatty acid synthesis and contributes to diet-induced obesity                                                    (full – 2005)  http://www.jci.org/articles/view/23057/version/1


Food for thought: endocannabinoid modulation of lipogenesis                    (full – 2005)











Endocannabinoids and food intake: newborn suckling and appetite regulation in adulthood.        (full – 2005)                              http://ebm.rsmjournals.com/cgi/content/full/230/4/225


Endocannabinoid activation at hepatic CB1 receptors stimulates fatty acid synthesis and contributes to diet-induced obesity                                             (full – 2005)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1087161/?tool=pmcentrez


Endocannabinoids in the Regulation of Appetite and Body Weight.            (abst – 2005)



Dysregulation of the Peripheral and Adipose Tissue Endocannabinoid System in Human Abdominal Obesity     (full – 2006)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2228260/?tool=pmcentrez


Regulation, Function, and Dysregulation of Endocannabinoids in Models of Adipose and ß-Pancreatic Cells and in Obesity and Hyperglycemia                                                        (full – 2006)  http://jcem.endojournals.org/cgi/content/full/91/8/3171?ijkey=83a68cef202eafe129332eda53eee8eb613499  82


AM 251 produces sustained reductions in food intake and body weight that are resistant to tolerance and conditioned taste aversion                                             (full – 2006)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1615836/?tool=pmcentrez


Weight Control in Individuals With Diabetes                  (full – 2006)  http://care.diabetesjournals.org/content/29/12/2749.full?maxtoshow=&hits=80&RESULTFORMAT=&full text=cannabis&searchid=1&FIRSTINDEX=2000&resourcetype=HWCIT


The emerging role of the endocannabinoid system in endocrine regulation and energy balance.    (full – 2006)                            http://edrv.endojournals.org/cgi/content/full/27/1/73


Does Cannabis Hold the Key to Treating Cardiometabolic Disease              (full – 2006)



Human adipose tissue binds and metabolizes the endocannabinoids anandamide and 2- arachidonoylglycerol.                                                   (abst – 2006)        http://www.ncbi.nlm.nih.gov/pubmed/16949718


Obesity – Acomplia: loss of a few kilos, many questions                 (news – 2006)



Identification of Endocannabinoids and Related Compounds in Human Fat Cells (full – 2007)                                   http://onlinelibrary.wiley.com/doi/10.1038/oby.2007.581/full


Genetic variations at the endocannabinoid type 1 receptor gene (CNR1) are associated with obesity phenotypes in men.                                                            (full – 2007)  http://jcem.endojournals.org/content/92/6/2382.long


The endogenous cannabinoid system: a new player in the brain-gut-adipose axis









(full – 2007)                    http://www.cannabis-med.org/english/journal/en_2007_02_1.pdf


No evidence for an involvement of variants in the cannabinoid receptor gene (CNR1) in obesity in German children and adolescents.                                                             (abst – 2007)  http://www.ncbi.nlm.nih.gov/pubmed/17292652


Endocannabinoid receptor 1 gene variations increase risk for obesity and modulate body mass index in European populations                                                         (full – 2008)  http://hmg.oxfordjournals.org/content/17/13/1916.long


GPR119, a novel G protein-coupled receptor target for the treatment of type 2 diabetes and obesity        (full – 2008)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2268073/?tool=pmcentrez


Activating Parabrachial Cannabinoid CB1 Receptors Selectively Stimulates Feeding of Palatable Foods in Rats                                                     (full – 2008)  http://www.jneurosci.org/cgi/content/full/28/39/9702?maxtoshow=&hits=80&RESULTFORMAT=&fullte   xt=cannabinoid&searchid=1&FIRSTINDEX=0&resourcetype=HWCIT


Emerging role of cannabinoids in gastrointestinal and liver diseases: basic and clinical aspects      (abst – 2008)                            http://gut.bmj.com/content/57/8/1140.abstract


Targeted enhancement of oleoylethanolamide production in proximal small intestine induces across-meal satiety in rats.                                                               (full – 2008)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2494809/?tool=pubmed


Endocannabinoids and the Control of Energy Homeostasis               (full – 2008)



The lipid messenger OEA links dietary fat intake to satiety.               (full – 2008)



The Role of Adipocyte Insulin Resistance in the Pathogenesis of Obesity-Related Elevations in Endocannabinoids                                                                  (full – 2008)  http://diabetes.diabetesjournals.org/content/57/5/1262.full?sid=00769f3d-54ab-451b-b69e-4650931c5e25


Genetic Variations at the Endocannabinoid Type 1 Receptor Gene (CNR1) Are Associated with Obesity Phenotypes in Men                                                        (full – 2008)  http://jcem.endojournals.org/cgi/content/full/92/6/2382


Endocannabinoid dysregulation in the pancreas and adipose tissue of mice fed with a high-fat diet.        (full – 2008)                       http://www.nature.com/oby/journal/v16/n3/full/oby2007106a.html


The role of endocannabinoids in the regulation of gastric emptying: alterations in mice fed a high-fat diet.          (full – 2008)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2275439/?tool=pubmed


Endocannabinoids and the Control of Energy Homeostasis              (full – 2008)











Dysregulation of peripheral endocannabinoid levels in hyperglycemia and obesity: Effect of high fat diets.                                            (abst – 2008)        http://www.ncbi.nlm.nih.gov/pubmed/18343566



(abst – 2008)               http://www.ncbi.nlm.nih.gov/pubmed/18638022


Dysregulation of peripheral endocannabinoid levels in hyperglycemia and obesity: Effect of high fat diets.                                          (abst – 2008)          http://www.ncbi.nlm.nih.gov/pubmed/18343566


Dysregulation of the endocannabinoid system in obesity.              (abst – 2008)



Cholesterol-induced stimulation of platelet aggregation is prevented by a hempseed- enriched diet.         (abst – 2008)                            http://www.ncbi.nlm.nih.gov/pubmed/18418423


Inhibitory effect of the anorexic compound oleoylethanolamide on gastric emptying in control and overweight mice.                                                    (abst – 2008)     http://www.ncbi.nlm.nih.gov/pubmed/18278475


Synthetic and plant-derived cannabinoid receptor antagonists show hypophagic properties in fasted and non-fasted mice                                                       (full – 2009)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2697695/?tool=pubmed


Peripheral endocannabinoid dysregulation in obesity: relation to intestinal motility and energy processing induced by food deprivation and re-feeding.                                                        (full – 2009)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2757684/?tool=pubmed


Cannabinoid CB2 Receptor Potentiates Obesity-Associated Inflammation, Insulin Resistance and Hepatic Steatosis                                                                  (full – 2009)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2688760/?tool=pubmed


Biomarkers of Endocannabinoid System Activation in Severe Obesity              (full – 2009)



The endocanabinnoid system and diabetes – critical analyses of studies conducted with rimonabant         (full – 2009)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2770455/?tool=pmcentrez


Cannabinoids for clinicians: the rise and fall of the cannabinoid antagonists   (full – 2009)  http://www.eje- online.org/cgi/content/full/161/5/655?maxtoshow=&hits=80&RESULTFORMAT=&fulltext=cannabinoid



Endocannabinoids and Their Receptors as Targets for Obesity Therapy               (full – 2009)



N-acylethanolamines, anandamide and food intake.              (abst – 2009)











Endocannabinoids and cardiovascular prevention: real progress?             (abst – 2009)



Effects of cannabinoid drugs on the reinforcing properties of food in gestationally undernourished rats.  (abst – 2009)                                      http://www.ncbi.nlm.nih.gov/pubmed/19602424


Anti-inflammatory effect of palmitoylethanolamide on human adipocytes.            (abst – 2009)



Natural Pot-Like Compound Could Fight Obesity               (news – 2009)



Alterations in the hippocampal endocannabinoid system in diet-induced obese mice. (full – 2010)                                     http://www.jneurosci.org/content/30/18/6273.long


Differential alterations of the concentrations of endocannabinoids and related lipids in the subcutaneous adipose tissue of obese diabetic patients                                                 (full – 2010)  http://www.lipidworld.com/content/9/1/43


Expression of cannabinoid CB1 receptors by vagal afferent neurons: kinetics and role in influencing neurochemical phenotype                                                           (full – 2010)  http://ajpgi.physiology.org/content/299/1/G63.full?sid=fc6948f0-78cf-405c-981b-afaa05ee417c


The endocannabinoid system links gut microbiota to adipogenesis               (full – 2010)



CD36 gene deletion decreases oleoylethanolamide levels in small intestine of free- feeding mice.  (full – 2010)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2846762/?tool=pubmed


A common CNR1 (cannabinoid receptor 1) haplotype attenuates the decrease in HDL cholesterol that typically accompanies weight gain.                                                         (full – 2010)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3013130/?tool=pubmed


The Effects of Rimonabant on Brown Adipose Tissue in Rat: Implications for Energy Expenditure          (full – 2010)                         http://www.nature.com/oby/journal/v17/n2/full/oby2008509a.html


Differential alterations of the concentrations of endocannabinoids and related lipids in the subcutaneous adipose tissue of obese diabetic patients.                                                 (full – 2010)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2868848/?tool=pubmed


Cannabinoid receptor stimulation impairs mitochondrial biogenesis in mouse white adipose tissue, muscle, and liver: the role of eNOS, p38 MAPK, and AMPK pathways. (full – 2010)                                     http://diabetes.diabetesjournals.org/content/59/11/2826.long#sec-25


A common polymorphism in the cannabinoid receptor 1 (CNR1) gene is associated with antipsychotic-induced weight gain in Schizophrenia.                                                      (full – 2010)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3055343/?tool=pubmed










Rehashing endocannabinoid antagonists: can we selectively target the periphery to safely treat obesity and type 2 diabetes?                                                       (full – 2010)  http://www.jci.org/articles/view/44099?search[abstract_text]=&search[article_text]=cannabinoid&search[a   uthors_text]=&search[fpage]=&search[title_text]=&search[volume]=


Modulation of Adipocyte Biology by Δ9-Tetrahydrocannabinol               (full – 2010)



Cannabidiol Attenuates the Appetitive Effects of Δ9-Tetrahydrocannabinol in Humans Smoking Their Chosen Cannabis                                                          (full – 2010)  http://www.nature.com/npp/journal/v35/n9/full/npp201058a.html


Perspectives of CB1 Antagonist in Treatment of Obesity: Experience of RIO-Asia (full – 2010)                                   http://www.hindawi.com/journals/jobes/2011/957268/


Deficiency of CB2 cannabinoid receptor in mice improves insulin sensitivity but increases food intake and obesity with age.                                                                      (abst – 2010)  http://www.springerlink.com/content/g037q1lh40l15161/


Analysis of gene expression pattern reveals potential targets of dietary oleoylethanolamide in reducing body fat gain in C3H mice.                                                                                         (abst – 2010)  http://www.ncbi.nlm.nih.gov/pubmed/19954948


G1359A polymorphism in the cannabinoid receptor-1 gene is associated with metabolic syndrome in the Chinese Han population.                                                        (abst – 2010)  http://www.ncbi.nlm.nih.gov/pubmed/20851297


Effect of dietary fat on endocannabinoids and related mediators: consequences on energy homeostasis, inflammation and mood.                                       (abst – 2010)  http://www.ncbi.nlm.nih.gov/pubmed/20013888


Cannabis Use and Obesity and Young Adults                (abst – 2010)



The endocannabinoid system modulates the valence of the emotion associated to food ingestion (abst – 2010)



Resistance to diet-induced adiposity in cannabinoid receptor-1 deficient mice is not due to impaired adipocyte function                                                       (full – 2011)  http://www.nutritionandmetabolism.com/content/8/1/93


Krill oil significantly decreases 2-arachidonoylglycerol plasma levels in obese subjects. (full – 2011)                                           http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3048484/?tool=pubmed


Effect of dietary krill oil supplementation on the endocannabinoidome of metabolically relevant tissues from high-fat-fed mice                                                             (full – 2011)  http://www.nutritionandmetabolism.com/content/8/1/51










Lipid transport function is the main target of oral oleoylethanolamide to reduce adiposity in high-fat-fed mice   (full – 2011)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3111743/?tool=pubmed


The activity of the endocannabinoid metabolising enzyme fatty acid amide hydrolase in subcutaneous adipocytes correlates with BMI in metabolically healthy humans

(full – 2011)                http://www.lipidworld.com/content/10/1/129


Sympathetic activity controls fat-induced oleoylethanolamide signaling in small intestine. (full – 2011)                                      http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3084524/?tool=pubmed


The association of the rs1049353 polymorphism of the CNR1 gene with hypoadiponectinemia.    (full – 2011)  http://www.rjme.ro/RJME/resources/files/520311791795.pdf


Gadolinium-HU-308-incorporated micelles.               (full – 2011)



Adipose tissue endocannabinoid system gene expression: depot differences and effects of diet and exercise       (full – 2011)                             http://www.lipidworld.com/content/10/1/194


Sweet taste and (AAT)12 repeat in the cannabinoid receptor gene in obese females (letter – 2011)                                          https://www.jstage.jst.go.jp/article/endocrj/58/4/58_K11E-093/_pdf


Psychiatric adverse effects of rimonobant in adults with Prader Willi syndrome. (abst – 2011)                                          http://www.ncbi.nlm.nih.gov/pubmed/20965292


The neutral cannabinoid CB₁ receptor antagonist AM4113 regulates body weight through

changes in energy intake in the rat.                   (abst – 2011)



Effects of Chronic Oral Rimonabant Administration on Energy Budgets of Diet-Induced Obese C57BL/6 Mice.                                                  (abst – 2011)         http://www.ncbi.nlm.nih.gov/pubmed/22173576


The role of central CB2 cannabinoid receptors on food intake in neonatal chicks. (abst – 2011)                                    http://www.ncbi.nlm.nih.gov/pubmed/21927979


Cannabidiol decreases body weight gain in rats: Involvement of CB2 receptors. (abst – 2011)                                   http://marijuana.researchtoday.net/archive/8/1/3517.htm


Obesity and Cannabis Use: Results From 2 Representative National Surveys (abst – 2011)

http://aje.oxfordjournals.org/content/early/2011/08/24/aje.kwr200.abstract?sid=18de840f-92a2-40d2-b154-  2e236ba97020









Are endocannabinoid type 1 receptor gene (CNR1) polymorphisms associated with obesity and metabolic syndrome in postmenopausal Polish women?                                                      (abst – 2011)  http://www.ncbi.nlm.nih.gov/pubmed/20838400


Frequency Of Marijuana Use Associated With Lower Prevalence Of Obesity, Study Says (news – 2011)                                           http://www.norml.org/index.cfm?Group_ID=8670


Smoking marijuana not linked to obesity: study              (news – 2011)



Body’s natural marijuana-like chemicals make fatty foods hard to resist              (news – 2011)



Binge Eating May Be a High All Its Own                (news – 2011)



To Be or Not To Be—Obese              (full – 2012)



The L-α-lysophosphatidylinositol/GPR55 system and its potential role in human obesity. (full – 2012)                                      http://diabetes.diabetesjournals.org/content/61/2/281.long


Resistance to diet-induced adiposity in cannabinoid receptor-1 deficient mice is not due to impaired adipocyte function.                                                (full – 2012)  http://www.nutritionandmetabolism.com/content/pdf/1743-7075-8-93.pdf


Homology modelling of CB1 receptor and selection of potential inhibitor against Obesity. (full – 2012)                                       http://www.ncbi.nlm.nih.gov/pubmed/22829723?dopt=Abstract


Cannabinoid Receptor 1 (CNR1) 4895 C/T Genetic Polymorphism was Associated with Obesity in Japanese Men.                                                             (full – 2012)  https://www.jstage.jst.go.jp/article/jat/19/8/19_12732/_pdf


Relationships between glucose, energy intake and dietary composition in obese adults with type 2 diabetes receiving the cannabinoid 1 (CB1) receptor antagonist, rimonabant (full – 2012)                                      http://www.nutritionj.com/content/11/1/50


Excess of the endocannabinoid anandamide during lactation induces overweight, fat accumulation and insulin resistance in adult mice                                                          (full – 2012)  http://www.dmsjournal.com/content/4/1/35


Hypothalamic 2-arachidonoylglycerol regulates multistage process of high-fat diet preferences.   (full – 2012)  http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0038609


Dietary linoleic acid elevates endogenous 2-AG and anandamide and induces obesity. (full – 2012)                                   http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3458187/









Over-Expression of Monoacylglycerol Lipase (MGL) in Small Intestine Alters Endocannabinoid Levels and Whole Body Energy Balance, Resulting in Obesity. (full – 2012)   http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3429419/


Diet-dependent modulation of hippocampal expression of endocannabinoid signaling- related proteins in cannabinoid antagonist-treated obese rats.                                                (full – 2012)  http://onlinelibrary.wiley.com/doi/10.1111/ejn.12012/full


Endocannabinoids measurement in human saliva as potential biomarker of obesity. (full – 2012)                                    http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3409167/?tool=pubmed


Metabolic effects of n-3 PUFA as phospholipids are superior to triglycerides in mice fed a high-fat diet: possible role of endocannabinoids.                                                         (full – 2012)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3372498/


Metabolic effects of n-3 PUFA as phospholipids are superior to triglycerides in mice fed a high-fat diet: possible role of endocannabinoids.                                                      (full – 2012)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3372498/


The dynamic nature of type 1 cannabinoid receptor (CB1) gene transcription (full – 2012)                                      http://onlinelibrary.wiley.com/doi/10.1111/j.1476-5381.2012.02175.x/full


Dietary linoleic acid elevates endogenous 2-arachidonoylglycerol and anandamide in Atlantic salmon (Salmo salar L.) and mice, and induces weight gain and inflammation in mice.   (abst – 2012)                         http://www.ncbi.nlm.nih.gov/pubmed/22883314


Dietary conditions and highly palatable food access alter rat cannabinoid receptor expression and binding density.                                                                   (abst – 2012)  http://www.ncbi.nlm.nih.gov/pubmed/22005165


The atypical cannabinoid O-1602 stimulates food intake and adiposity in rats. (abst – 2012)                                     http://www.ncbi.nlm.nih.gov/pubmed/21981246


Cannabinoid signalling regulates inflammation and energy balance: The importance of the brain-gut axis.                                          (abst – 2012)         http://www.ncbi.nlm.nih.gov/pubmed/22269477


Cannabis exposure associated with weight reduction and β-cell protection in an obese rat model. (abst – 2012)                        http://www.ncbi.nlm.nih.gov/pubmed/22421529


Anti-obesity effects of the combined administration of CB1 receptor antagonist rimonabant and melanin-concentrating hormone antagonist SNAP-94847 in diet-inudced obese mice.         (abst – 2012)                                http://www.ncbi.nlm.nih.gov/pubmed/22473329


Overexpression of cannabinoid CB2 receptor in the brain induces hyperglycaemia and a lean phenotype in adult mice.                                                   (abst – 2012)      http://www.ncbi.nlm.nih.gov/pubmed/22487302


Cannabinol and cannabidiol exert opposing effects on rat feeding patterns.   (abst – 2012)











The thrifty lipids: endocannabinoids and the neural control of energy conservation. (abst – 2012)                                     http://www.ncbi.nlm.nih.gov/pubmed/22622030


Stimulation of acumbens shell cannabinoid CB(1) receptors by noladin ether, a putative endocannabinoid, modulates food intake and dietary selection in rats.                                           (abst – 2012)  http://www.ncbi.nlm.nih.gov/pubmed/22728691


Associations of variants of CNR1 with obesity and obesity-related traits in Chinese women.        (abst – 2012)                          http://www.ncbi.nlm.nih.gov/pubmed/22244745


Photoperiodic Changes in Endocannabinoid Levels and Energetic Responses to Altered Signalling at CB1 Receptors in Siberian Hamsters                                               (abst – 2012)  http://onlinelibrary.wiley.com/doi/10.1111/j.1365-2826.2012.02312.x/abstract


The role of the endocannabinoid system in eating disorders: pharmacological implications.           (abst – 2012)                                    http://www.ncbi.nlm.nih.gov/pubmed/22785439


Hypothalamic CB1 Cannabinoid Receptors Regulate Energy Balance in Mice. (abst – 2012)                                      http://www.ncbi.nlm.nih.gov/pubmed/22778221


1-               Arachidonoylglycerol Signaling in Forebrain Regulates Systemic Energy Metabolism (abst – 2012)           http://www.sciencedirect.com/science/article/pii/S1550413112000526


The potential use of cannabidiol in the therapy of metabolic syndrome              (abst – 2012)



GPR119 as a fat sensor.             (abst – 2012)       http://www.ncbi.nlm.nih.gov/pubmed/22560300


Hedonic eating is associated with increased peripheral levels of ghrelin and the endocannabinoid 2-arachidonoyl-glycerol in healthy humans: a pilot study. (abst – 2012)       http://www.ncbi.nlm.nih.gov/pubmed/22442280


Role of G1359A polymorphism of the cannabinoid receptor gene on weight loss and adipocytokines levels after two different hypocaloric diets.                                                                  (abst – 2012)  http://www.ncbi.nlm.nih.gov/pubmed/21543209


The role of the endocannabinoid system in skeletal muscle and metabolic adaptations to exercise: potential implications for the treatment of obesity.                                              (abst – 2012)  http://www.ncbi.nlm.nih.gov/pubmed/22943701


Childhood Obesity and the Role of Dopamine D2 Receptor and Cannabinoid Receptor-1 Gene Polymorphisms.                                                   (abst – 2012)         http://www.ncbi.nlm.nih.gov/pubmed/23057570


Hypothalamic CB1 Cannabinoid Receptors Regulate Energy Balance in Mice (abst – 2012)










The role of the endocannabinoid system in skeletal muscle and metabolic adaptations to exercise: potential implications for the treatment of obesity                                                     (abst – 2012)  http://onlinelibrary.wiley.com/doi/10.1111/j.1467-789X.2012.01026.x/abstract


Cannabinoid Type 1 Receptor Gene Polymorphism and Macronutrient Intake. (abst – 2012)                                           http://www.ncbi.nlm.nih.gov/pubmed/23207972


New vistas for treatment of obesity and diabetes? Endocannabinoid signalling and metabolism in the modulation of energy balance.                                                                             (abst – 2012)  http://www.ncbi.nlm.nih.gov/pubmed/22674489


Fatty acid flux and oxidation are increased by rimonabant in obese women. (abst – 2012)                                            http://www.ncbi.nlm.nih.gov/pubmed/22445512


How marijuana could help cure obesity-related diseases                      (news – 2012)



Cannabis can help treat obesity                     (news – 2012)



Marijuana Slims? Why Pot Smokers Are Less Obese                     (news – 2012)  http://healthland.time.com/2011/09/08/marijuana-slims-pot-smoking-linked-to-lower-body-   weight/#ixzz21IEZq1Lg


Fight obesity… with marijuana?                     (news – 2012)



Genetic variation in the cannabinoid receptor gene (CNR1) (G1359A polymorphism) and their influence on anthropometric parameters and metabolic parameters under a high monounsaturated vs. high polyunsaturated fat hypocaloric diets.                                                                                               (abst – 2013)  http://www.ncbi.nlm.nih.gov/pubmed/23337343


Insulin induces long-term depression of ventral tegmental area dopamine neurons via endocannabinoids (abst – 2013)  http://www.nature.com/neuro/journal/vaop/ncurrent/full/nn.3321.html


Cannabis and Δ(9)-tetrahydrocannabinol (THC) for weight loss?                         (abst – 2013)



Endocannabinoids and obesity.                 (abst – 2013)  http://www.ncbi.nlm.nih.gov/pubmed/23374723

Share a link for